<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DB3BCEAD-7AF1-453F-B56E-8CEA2199DA0F"><gtr:id>DB3BCEAD-7AF1-453F-B56E-8CEA2199DA0F</gtr:id><gtr:firstName>Venugopal</gtr:firstName><gtr:surname>Nair</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FK011057%2F1"><gtr:id>82C2E853-D9A7-4407-9380-A4E8673141B1</gtr:id><gtr:title>Vaccines as drivers of disease emergence: transmission ecology and virulence evolution in Marek's disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K011057/1</gtr:grantReference><gtr:abstractText>See Lead Investigator application to NSF</gtr:abstractText><gtr:technicalSummary>See Lead Investigator application to NSF</gtr:technicalSummary><gtr:potentialImpactText>Global demand for food is rising, both as a result of population growth and due to dietary changes in developing countries. Recent UN FAO report on this issue forecasts that food production will need to increase by over 40% by 2030 and by over 70% by 2050. With close to 55 billion chickens reared annually, poultry meat and eggs dominate animal protein products for human consumption world-wide. In the UK, the poultry sector is thought to contribute around &amp;pound;3.4 billion to the economy. Compared to the other livestock sectors, the modern poultry production methods have the most efficient feed-tomeat conversion ratios with lowest global warming potential. Because of these attributes, the poultry production sector will expand significantly to meet the global demand for food in the coming years. Infectious diseases, particularly caused by a plethora of highly contagious viral pathogens, remain a major threat for efficient poultry production. Marek's disease (MD) caused by the highly contagious and oncogenic herpesvirus, Marek's disease virus (MDV), is one of the major diseases of poultry which causes serious economic losses of up to $2,000 million annually. Control of MD is achieved by the use of more than 22,000 million doses of vaccines, with an estimated value of $400 million. Institute for Animal Health has been in the forefront of research on Marek's disease for over 5o years and was instrumental in identifying the causative agent and development of the first MD vaccine. IAH has been collaborating with the Lead Applicant for several years and have demonstrated the significant potential role of vaccines in driving the virulence. Financial benefits from the research on Marek's disease at the Institute for Animal Health was shown in a recent DTZ study (2009) to be at &amp;pound;297 million since 2003/04 with the potential to save up to &amp;pound;1.4 billion. Similarly, another study (PA consultancy 2007) showed that MD vaccines and validation tests developed at IAH contributes to the to worldwide market value of $400 million. The present proposal examining the transmission ecology and virulence evolution in Marek's disease, together with examining the role of vaccines as drivers of disease emergence will have a major impact on our understanding of the disease, the current methods of control and will help to develop new approaches for intervention.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>992013</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>our study demonstrated that some of the vaccines against veterinary diseases that do not prevent transmission may contribute to increase in virulence</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>8000FAFF-53A8-486C-B73E-3550CAE76A7C</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic,Policy &amp; public services</gtr:impactType></gtr:impactTypes><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Through the major publication 'Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens' as part of this grant, we have demonstrated that vaccines against avian diseases can enhance virulence of pathogens. This publication received extensive press coverage and became a major discussion point (see below)
?The Washington Post: &amp;quot;Imperfect vaccines could make viruses more dangerous, at least in chickens&amp;quot; 27 Jul 2015
?Science/AAAS: &amp;quot;Could some vaccines make diseases more deadly?&amp;quot; 27 Jul 2015
?ScienceDaily: &amp;quot;Some vaccines support evolution of more-virulent viruses&amp;quot; 27 Jul 2015
?ouest-france: &amp;quot;Some vaccines boost the dangerousness of certain viruses&amp;quot; 29 Jul 2015
?PBS Newshour: &amp;quot;This chicken vaccine makes its virus more dangerous&amp;quot; 27 Jul 2015
?Newsweek: &amp;quot;'Leaky' Vaccines May Create Stronger Viruses&amp;quot; 27 Jul 2015
?WorldPoultry: &amp;quot;Study: Poultry at risk from 'leaky' Marek's vaccination&amp;quot; 3 Aug 2015
?Sixactualites: &amp;quot;Vaccines may render more dangerous viruses&amp;quot; 20 Aug 2015
?Vincent Racaniello: &amp;quot;Permissive vaccines and viral virulence&amp;quot; 30 Jul 2015
?Poultrymed: &amp;quot;Leaky vaccines: Vaccination could prompt the evolution of more virulent pathogens&amp;quot; 27 Jul 2015
?Slashdot: &amp;quot;Study: Certain Vaccines Could Make Diseases More Deadly&amp;quot;
?This Week in Virology: &amp;quot;TWiV 348: Chicken shift&amp;quot;</gtr:description><gtr:exploitationPathways>The findings from the project could be used to examine this other vaccines and in developing next generation vaccines that stops/reduces shedding</gtr:exploitationPathways><gtr:id>E9F1DF11-5B8A-4AE1-81E9-39676EEB6F97</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.bbsrc.ac.uk/news/health/2015/150729-pr-imperfect-vaccines-individuals-greater-risk-severe-illness/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1EAC89C9-7589-4E3F-B09A-46265FEBAD8E"><gtr:id>1EAC89C9-7589-4E3F-B09A-46265FEBAD8E</gtr:id><gtr:title>Molecular characterization of Marek's disease virus in a poultry layer farm from Colombia.</gtr:title><gtr:parentPublicationTitle>Poultry science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/35e1df88bbf119bf249121716bc2697c"><gtr:id>35e1df88bbf119bf249121716bc2697c</gtr:id><gtr:otherNames>L?pez-Osorio S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0032-5791</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FB03734-D9F1-46E1-9A89-4D75FDE93168"><gtr:id>6FB03734-D9F1-46E1-9A89-4D75FDE93168</gtr:id><gtr:title>Replication defective adenovirus serotype 5 expressing Marek's disease virus envelope glycoprotein as a potential Marek's disease vaccine in chicken</gtr:title><gtr:parentPublicationTitle>Journal of Veterinary Medicine and Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7ae640df89a020942516dc56e726e29a"><gtr:id>7ae640df89a020942516dc56e726e29a</gtr:id><gtr:otherNames>Baigent SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D404442F-BE94-4070-84E8-E4FB71060745"><gtr:id>D404442F-BE94-4070-84E8-E4FB71060745</gtr:id><gtr:title>Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa53fa09bec5636184d1b55539c81017"><gtr:id>aa53fa09bec5636184d1b55539c81017</gtr:id><gtr:otherNames>Read AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8AD115FA-A6F8-4F47-BB9D-1DD2C9D363B0"><gtr:id>8AD115FA-A6F8-4F47-BB9D-1DD2C9D363B0</gtr:id><gtr:title>Replication defective adenovirus serotype 5 expressing Marek's disease virus envelope glycoprotein as a potential Marek's disease vaccine in chicken</gtr:title><gtr:parentPublicationTitle>Journal of Veterinary Medicine and Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1774f82f030a4767e55f9ffe9d84864"><gtr:id>c1774f82f030a4767e55f9ffe9d84864</gtr:id><gtr:otherNames>Baijent SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K011057/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>C23BE70F-1EF6-4CC7-88B0-841CB18DD875</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Genetics &amp; development</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>2607D197-52EE-40CA-A1D5-A46D18C3F97F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Microbial sciences</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>A502D25A-BB70-4F74-844D-32A2BAD075A5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Diseases</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>62F9C365-02D0-4623-9A73-8CA09DA0FFF2</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Evolution &amp; populations</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>5BA89E2C-27FE-4553-819B-3CE27FC71EC2</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Microbiology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>75BBF8D4-D2E9-4106-B484-743614789AF9</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Microorganisms</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>